What is Bolt Biotherapeutics?
operates as a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company offers product candidates and platform technologies, including PRA-216, BDC-4182, a Boltbody ISAC that targets the tumor-associated antigen claudin 18. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 12.80M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 938,584 shares $128k | 3103,094 shares $629k |
| 3-6months | 0 | 21,146 shares $4k |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 2250 shares $1k |